• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Biotechnol . Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children

tetano

Editor, Senior Moderator
Nat Biotechnol


. 2021 Aug 18.
doi: 10.1038/s41587-021-01037-9. Online ahead of print.
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children


J Loske[SUP] #[/SUP][SUP] 1 [/SUP], J Röhmel[SUP] #[/SUP][SUP] 2 [/SUP], S Lukassen[SUP] #[/SUP][SUP] 3 [/SUP], S Stricker[SUP] 2 [/SUP], V G Magalhães[SUP] 4 [/SUP], J Liebig[SUP] 3 [/SUP], R L Chua[SUP] 3 [/SUP], L Thürmann[SUP] 1 [/SUP], M Messingschlager[SUP] 1 [/SUP], A Seegebarth[SUP] 1 [/SUP], B Timmermann[SUP] 5 [/SUP], S Klages[SUP] 5 [/SUP], M Ralser[SUP] 6 [/SUP], B Sawitzki[SUP] 7 [/SUP], L E Sander[SUP] 8 9 [/SUP], V M Corman[SUP] 10 11 [/SUP], C Conrad[SUP] 3 [/SUP], S Laudi[SUP] 12 [/SUP], M Binder[SUP] 4 [/SUP], S Trump[SUP] 1 [/SUP], R Eils[SUP] 13 14 15 [/SUP], M A Mall[SUP] 2 9 [/SUP], I Lehmann[SUP] 1 9 16 [/SUP]



Affiliations

Abstract

Children have reduced severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates and a substantially lower risk for developing severe coronavirus disease 2019 compared with adults. However, the molecular mechanisms underlying protection in younger age groups remain unknown. Here we characterize the single-cell transcriptional landscape in the upper airways of SARS-CoV-2-negative (n = 18) and age-matched SARS-CoV-2-positive (n = 24) children and corresponding samples from adults (n = 44), covering an age range of 4 weeks to 77 years. Children displayed higher basal expression of relevant pattern recognition receptors such as MDA5 (IFIH1) and RIG-I (DDX58) in upper airway epithelial cells, macrophages and dendritic cells, resulting in stronger innate antiviral responses upon SARS-CoV-2 infection than in adults. We further detected distinct immune cell subpopulations including KLRC1 (NKG2A)[SUP]+[/SUP] cytotoxic T cells and a CD8[SUP]+[/SUP] T cell population with a memory phenotype occurring predominantly in children. Our study provides evidence that the airway immune cells of children are primed for virus sensing, resulting in a stronger early innate antiviral response to SARS-CoV-2 infection than in adults.
 
Back
Top Bottom